Methotrexate Biodim

Methotrexate, the active ingredient in Methotrexate Biodim, is an Antimetabolite presented as a sterile solution for intraarterial, intramuscular, intrathecal use. It is employed in the management of rheumatoid arthritis, psoriasis, certain leukemias and lymphomas, and gestational trophoblastic disease.

GNH USA supplies Methotrexate Biodim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Methotrexate is used across several disease families, primarily as an antimetabolite that interferes with rapidly dividing cells. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: diminishes skin plaque formation and severity. - Acute lymphoblastic leukemia: induces remission by inhibiting malignant lymphoblast proliferation. - Non‑Hodgkin lymphoma: contributes to tumor control in combination regimens. - Gestational trophoblastic disease: promotes resolution of abnormal trophoblastic tissue.

Methotrexate may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea and vomiting: mild to moderate gastrointestinal upset. - Mucositis: inflammation of the oral mucosa. - Elevated liver enzymes: transient hepatic enzyme rise. - Fatigue: general tiredness or weakness.

Serious or Rare Side Effects: - Myelosuppression: significant reduction in blood cell counts. - Pulmonary toxicity: interstitial pneumonitis or fibrosis. - Severe hepatotoxicity: potential for liver fibrosis or cirrhosis. - Renal impairment: decreased renal function or acute kidney injury.

Methotrexate requires careful monitoring and specific safety measures. - Renal function: assess creatinine clearance before and during therapy. - Hepatic health: perform baseline and periodic liver function tests. - Hematologic monitoring: regular complete blood counts to detect myelosuppression. - Pregnancy risk: avoid use in pregnancy due to teratogenic potential; effective contraception required. - Drug interactions: review concomitant medications for potential additive toxicity. - Store at ambient temperature: keep in original container, protect from moisture and light.

Methotrexate interacts with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - NSAIDs: increase risk of renal toxicity and myelosuppression. - Proton pump inhibitors: may elevate methotrexate plasma levels. - Trimethoprim‑sulfamethoxazole: potentiates hematologic toxicity.

Moderate Interactions (Monitor Closely): - Penicillins: may reduce renal clearance of methotrexate. - Phenytoin: can alter hepatic metabolism. - Live vaccines: risk of infection due to immunosuppression.